Unknown

Dataset Information

0

SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.


ABSTRACT: Human embryonic stem cells (hESCs) are a unique in vitro model for studying human developmental biology and represent a potential source for cell replacement strategies. Platelets can be generated from cord blood progenitors and hESCs; however, the molecular mechanisms and determinants controlling the in vitro megakaryocytic specification of hESCs remain elusive. We have recently shown that stem cell leukemia (SCL) overexpression accelerates the emergence of hemato-endothelial progenitors from hESCs and promotes their subsequent differentiation into blood cells with higher clonogenic potential. Given that SCL participates in megakaryocytic commitment, we hypothesized that it may potentiate megakaryopoiesis from hESCs. We show that ectopic SCL expression enhances the emergence of megakaryocytic precursors, mature megakaryocytes (MKs), and platelets in vitro. SCL-overexpressing MKs and platelets respond to different activating stimuli similar to their control counterparts. Gene expression profiling of megakaryocytic precursors shows that SCL overexpression renders a megakaryopoietic molecular signature. Connectivity Map analysis reveals that trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), both histone deacetylase (HDAC) inhibitors, functionally mimic SCL-induced effects. Finally, we confirm that both TSA and SAHA treatment promote the emergence of CD34(+) progenitors, whereas valproic acid, another HDAC inhibitor, potentiates MK and platelet production. We demonstrate that SCL and HDAC inhibitors are megakaryopoiesis regulators in hESCs.

SUBMITTER: Toscano MG 

PROVIDER: S-EPMC4426806 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

Toscano Miguel G MG   Navarro-Montero Oscar O   Ayllon Veronica V   Ramos-Mejia Veronica V   Guerrero-Carreno Xiomara X   Bueno Clara C   Romero Tamara T   Lamolda Mar M   Cobo Marien M   Martin Francisco F   Menendez Pablo P   Real Pedro J PJ  

Molecular therapy : the journal of the American Society of Gene Therapy 20141008 1


Human embryonic stem cells (hESCs) are a unique in vitro model for studying human developmental biology and represent a potential source for cell replacement strategies. Platelets can be generated from cord blood progenitors and hESCs; however, the molecular mechanisms and determinants controlling the in vitro megakaryocytic specification of hESCs remain elusive. We have recently shown that stem cell leukemia (SCL) overexpression accelerates the emergence of hemato-endothelial progenitors from h  ...[more]

Similar Datasets

| S-EPMC3392972 | biostudies-literature
| S-EPMC1950955 | biostudies-literature
| S-EPMC1895859 | biostudies-literature
| S-EPMC3709577 | biostudies-literature
| S-EPMC4817813 | biostudies-literature
| S-EPMC4388500 | biostudies-literature
2009-06-19 | GSE15806 | GEO
2009-06-19 | E-GEOD-15806 | biostudies-arrayexpress
| S-EPMC3837340 | biostudies-literature
| S-EPMC5100561 | biostudies-literature